Raymond James on Court Ruling: 'This should be viewed as a positive OSCR and other ACA exchange players as this puts to bed the $5 rule'

June 15, 2026 9:04 AM

Raymond James analyst John Ransom reiterated an Outperform rating and $30.00 price target on Oscar Health Inc (NYSE: OSCR).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

Raymond James on Court Ruling: 'This should be viewed as a positive OSCR and other ACA exchange players as this puts to bed the $5 rule'

Categories